首页> 外文期刊>Journal of the American Chemical Society >Sugar-Breathing Glycopolymersomes for Regulating Glucose Level
【24h】

Sugar-Breathing Glycopolymersomes for Regulating Glucose Level

机译:调糖糖调节糖水平

获取原文
获取原文并翻译 | 示例
       

摘要

Diabetes mellitus is a chronic, life-threatening illness that affects people of every age and ethnicity. It is a long-term pain for those who are affected and must regulate their blood glucose level by frequent subcutaneous injection of insulin every day. Herein, we propose a noninsulin and antidiabetic drug-free strategy for regulating blood glucose level by a nanosized "sugar sponge" which is a lectin-bound glycopolymersome capable of regulating glucose due to the dynamic recognition between the lectin and different carbohydrates. The glycopolymersome is self-assembled from poly(ethylene oxide)-block-poly[(7-(2-methacryloyloxye- thoxy)-4-methylcoumarin)-stat-2-(diethylamino)ethyl methacrylate-stat-(α-D-glucopyranosyl)ethyl methacrylate] [PEO-b-P- (CMA-stat-DEA-stat-GEMA)]. The lectin bound in the glycopolymersome has different affinity for the glucose in the blood and the glucosyl group in the glycopolymersome. Therefore, this sugar sponge functions as a glucose storage unit by dynamic sugar replacement: The lectin in the sugar sponge will bind and store the glucose from its surrounding solution when the glucose concentration is too high and will release the glucose when the glucose concentration is too low. In vitro, this sugar-breathing behavior is characterized by a remarkable size change of the sugar sponge due to the swelling/shrinkage at high/low glucose levels, which can be used for blood sugar monitoring. In vivo, this sugar sponge showed an excellent antidiabetic effect for type I diabetic mice within 2 days upon one dose, which is much longer than traditional long-acting insulin. Overall, this concept of "controlling sugar levels with sugar" opens new avenues for regulating the blood glucose level without the involvement of insulin or other antidiabetic drugs.
机译:糖尿病是一种威胁生命的慢性疾病,会影响各个年龄段和不同种族的人。对于受影响的人来说,这是一种长期的痛苦,必须每天通过每天皮下注射胰岛素来调节血糖水平。本文中,我们提出了一种非胰岛素和抗糖尿病的无药策略,可通过纳米尺寸的“糖海绵”调节血糖水平,这种糖是一种由于凝集素与不同碳水化合物之间的动态识别而能够调节葡萄糖的凝集素结合型糖聚合物。糖多聚体是由聚(环氧乙烷)-嵌段-聚[(7-(2-甲基丙烯酰氧基-乙氧基)-4-甲基香豆素)-stat-2-(二乙氨基)甲基丙烯酸乙酯-stat-((α-D-甲基丙烯酸吡喃葡萄糖基)]] [PEO-bP-(CMA-stat-DEA-stat-GEMA)]。结合在糖多聚体中的凝集素对血液中的葡萄糖和糖多聚体中的葡糖基具有不同的亲和力。因此,这种糖海绵通过动态糖替代而充当葡萄糖存储单元:糖海绵中的凝集素会在葡萄糖浓度过高时结合并从周围溶液中储存葡萄糖,而在葡萄糖浓度过高时会释放出葡萄糖。低。在体外,这种糖呼吸行为的特征是由于在高/低葡萄糖水平下的溶胀/收缩,糖海绵的尺寸发生了显着变化,可用于血糖监测。在体内,这种糖海绵对一型糖尿病小鼠在一次给药后的两天内显示出优异的抗糖尿病作用,比传统的长效胰岛素长得多。总体而言,“用糖控制糖水平”这一概念为不使用胰岛素或其他抗糖尿病药而调节血糖水平开辟了新途径。

著录项

  • 来源
    《Journal of the American Chemical Society》 |2017年第22期|7640-7647|共8页
  • 作者单位

    Department of Polymeric Materials, School of Materials Science and Engineering, Tongji University, 4800 Caoan Road, Shanghai 201804, China;

    Department of Polymeric Materials, School of Materials Science and Engineering, Tongji University, 4800 Caoan Road, Shanghai 201804, China;

    Department of Polymeric Materials, School of Materials Science and Engineering, Tongji University, 4800 Caoan Road, Shanghai 201804, China,Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 03:07:57

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号